Publisher: Wiley-Blackwell

Related content
Volume 13, Number 6, June 2011

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Pharmaceutical interventions for obesity: a public health perspective
pp. 490-497(8)
Authors: Caveney, E.; Caveney, B. J.; Somaratne, R.; Turner, J. R.; Gourgiotis, L.

Favourites:Add to Favourites

Effects of an 11-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
pp. 498-504(7)
Authors: Feig, P. U.; Shah, S.; Hermanowski-Vosatka, A.; Plotkin, D.; Springer, M. S.; Donahue, S.; Thach, C.; Klein, E. J.; Lai, E.; Kaufman, K. D.

Favourites:Add to Favourites
Favourites:Add to Favourites

Insulin dose–response studies in severely insulin-resistant type 2 diabetes—evidence for effectiveness of very high insulin doses
pp. 511-516(6)
Authors: Kampmann, U.; Hoeyem, P.; Mengel, A.; Schmitz, O.; Rungby, J.; Orskov, L.; Møller, N.

Favourites:Add to Favourites

Association of -2 adrenergic agonist and corticosteroid injection in the treatment of lipomas
pp. 517-522(6)
Authors: Redman, L. M.; Moro, C.; Dobak, J.; Yu, Y.; Guillot, T. S.; Greenway, F. L.

Favourites:Add to Favourites

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment
pp. 523-532(10)
Authors: Nowicki, M.; Rychlik, I.; Haller, H.; Warren, M. L.; Suchower, L.; Gause-Nilsson, I.

Favourites:Add to Favourites

Telmisartan, a dual ARB/partial PPAR- agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes
pp. 533-541(9)
Authors: Goyal, S. N.; Bharti, S.; Bhatia, J.; Nag, T. C.; Ray, R.; Arya, D. S.

Favourites:Add to Favourites

The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus
pp. 542-550(9)
Authors: Forst, T.; Uhlig-Laske, B.; Ring, A.; Ritzhaupt, A.; Graefe-Mody, U.; Dugi, K. A.

Favourites:Add to Favourites

Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation
pp. 551-558(8)
Authors: Stunes, A. K.; Reseland, J. E.; Hauso, Ø.; Kidd, M.; Tømmerås, K.; Waldum, H. L.; Syversen, U.; Gustafsson, B. I.

Favourites:Add to Favourites

A cohort study of acute pancreatitis in relation to exenatide use
pp. 559-566(8)
Authors: Dore, D. D.; Bloomgren, G. L.; Wenten, M.; Hoffman, C.; Clifford, C. R.; Quinn, S. G.; Braun, D. K.; Noel, R. A.; Seeger, J. D.

Favourites:Add to Favourites

Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks
pp. 567-576(10)
Authors: Pfützner, A.; Paz-Pacheco, E.; Allen, E.; Frederich, R.; Chen, R.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more